1. Home
  2. Live Updates
  3. Novel coronaviruses

Live Breaking News & Updates on Novel coronaviruses

Stay informed with the latest breaking news from Novel coronaviruses on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Novel coronaviruses and stay connected to the pulse of your community

Pfizer Stock Has 29% Upside, Says a New Bull

Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.

Emily-dattilo , Pfizer , Courtesy-pfizer , Vamil-divan , Dow-jones-market , Wall-street , Article-normal , Pharmaceuticals , Vaccines , Textiles , Wholesalers

Moderna posts surprise quarterly profit even as COVID sales continue to slide

Moderna on Thursday reported a surprise fourth-quarter profit even as its COVID product sales continue to plunge.

Moderna-spikevax , Stephane-bancel , Centers-for-disease , Drug-administration , Merck-co , Vaccine-alliance , Moderna-inc , Chief-financial-officer-jamey-mock , Executive-stephane-bancel , Disease-control , Article-normal , Biotechnology

Moderna Stock Jumps on Surprise Profit, Sales Ahead of Expectations

Vaccine maker Moderna reported a profit of 55 cents a share on revenue of $2.8 billion in the December quarter, beating analysts’ expectations.

Jack-denton , Getty-images , Wall-street , Article-normal , Biotechnology-services , Pharmaceuticals , Vaccines , Healthcare-life-sciences , Specialized-drugs-medications , Financial-performance , Earnings

Novavax Stock Soars 26%. A Vaccine Purchase Settlement Is One Reason Why.

Novavax reaches a settlement related to an advance purchase agreement with Gavi.

John-jacobs , Angela-palumbo , Drug-administration , Getty-images , Novavax-chief-executive , Dow-jones-market , Wall-street , Article-normal , Pharmaceuticals , Vaccines , Textiles , Healthcare-life-sciences

Sonic Healthcare 1H Net Profit A$202.3 Million, Down 47% on Year

By David Winning SYDNEY--Sonic Healthcare said its net profit fell by 47% on a steep drop in Covid-19 testing volumes, but it has benefited from recent...

Australia , Sydney , New-south-wales , Australian , Colin-goldschmidt , Sonic-healthcare , Utah-based-pathology-watch , Executive-colin-goldschmidt , David-winning , Article-normal , Healthcare-life-sciences

DaVita Stock Gains. Volumes Are Improving After Covid-19.

DaVita expects to earnings to be between $8.70 a share and $9.80 a share for the full year.

David-macdonald , Javier-rodriguez , Kevin-fischbeck , Angela-palumbo , Wall-street , Truist-securities , Article-normal , Printing-publishing , Media-entertainment , Financial-performance , Share-price-movement-disruptions

Expanding the child tax credit could come from axing this fraud 'magnet'

Congress is considering a new bipartisan tax package that would expand the child tax credit and restore several business tax breaks, and the plan is to end a...

United-states , Ukraine , Washington , American , Henrietta-treyz , Maya-macguineas , John-buhl , Steve-pavlick , Danny-werfel , Committee-on-taxation , Tax-foundation , Renaissance-macro-research

Why Wait on Rate Cuts? Post-Covid Economic Changes Warrant Caution, Barkin Says.

The president of the Richmond Fed said changes in the labor market and housing, plus deglobalization, could affect inflation.

New-york , United-states , Richmond , Virginia , Tom-barkin , Megan-leonhardt , Thomas-barkin , Jay-paul-bloomberg , Economic-club-of-new-york , Federal-reserve-bank , Virginia-chamber , Virginia-bankers-association

Quest 4Q Net Up as Diagnostic Demand Offsets Plunge in Covid Testing

By Rob Curran Quest Diagnostics said fourth-quarter net income surged 90% as increased medical testing for miscellaneous conditions more than offset a near...

United-states , Americans , Rob-curran , Quest-diagnostics , Wall-street , Article-normal , Healthcare-life-sciences , Medical-laboratory-services , Healthcare-support-services , Diagnostic-medical-research-services , Financial-performance , Corporate-industrial-news

This Epidemiologist Has a Plan to Win Back Public Trust After Covid

“People can handle uncertainty,” says Dr. Sandro Galea, author of the new book Within Reason: A Liberal Public Health for an Illiberal Time.

Courtesy-of-the-university-chicago , A-liberal-public-health , Boston-university-school-of-public-health , World-health-organization , Sandro-galea , Chicago-press , Boston-university-school , Public-health , Within-reason , Liberal-public-health , Article-normal